Extended Release Drug Delivery Technology

The article by Dr. Siegel in the June 2005 edition of your journal [Extended Release Drug Delivery Strategies in Psychiatry: Theory to Practice. Psychiatry 2005 2005;2(6):22–31] was quite a relevant and 35 piece. I was particularly interested in the aspects that dealt with substance abuse treatment, which touched on the extended-release injectable form of naltrexone.

Another medication currently in the pipeline is a new, extended-release formulation of buprenorphine, which is a depot form. This depot formulation is an injectable solution that contains tiny biodegradable capsules of buprenorphine. As the capsules disintegrate, it is said that it would be slowly released over several weeks, and it would be administered once every 4 to 6 weeks.

Diversion of medications in substance abuse treatments, whether it be medications like methadone, benzodiazepines, or narcotic analgesics, has been a huge problem. Buprenorphine, a partial opiate agonist, was given FDA approval in October 2002 for treatment of...

See Also: Extended Release Drug Delivery Strategies

Read More!

Overview of Controlled Release Mechanisms

Abstract

Controlled release systems have been developed to improve the temporal and spatial presentation of drug in the body, to protect drug from physiological degradation or elimination, to improve patient compliance, and to enhance quality control in manufacturing of drug products. When designing controlled-release systems, it is important to identify and understand particular mechanisms involve in the release process. Often, more than one mechanism is involved at a given time or different mechanisms may dominate at different stages of the drug delivery process. This chapter begins with several vignettes, each highlighting a mode of controlled drug delivery and identifying associated mechanisms. An introductory description of several of the mechanisms follows. Details regarding these mechanisms are provided in subsequent chapters.

2.1 Introduction

Controlled-release systems are designed to enhance drug therapy. There are several motivations for developing controlled-release systems, which may depend on the drug of interest. Controlled release systems have been devised to enable superior control of...

Read More!

The Long-term Psychological Effects of Daily Sedative Interruption on Critically Ill Patients

Critically ill patients often receive sedatives, which may delay liberation from mechanical ventilation and intensive care unit discharge. Daily interruption of sedatives alleviates these problems, but the impact of this practice on long-term psychological outcomes is unknown. We compared psychological outcomes of intensive care unit patients undergoing daily sedative interruption (intervention) with those without this protocol (control). Assessments using (1) the Revised Impact of Event Scale (evaluates signs of posttraumatic stress disorder [PTSD]), (2) the Medical Outcomes Study 36 item short-form health survey, (3) the State-Trait Anxiety Inventory, (4) the Beck Depression Inventory-2, (5) and the Psychosocial Adjustment to Illness score (overall quality of adjustment to current or residual effects of illness) were done by blinded observers. The intervention group had a better total Impact of Events score (11.2 vs. 27.3, p  0.02), a trend toward a lower incidence of PTSD (0% vs. 32%, p  0.06), and a trend toward a better total Psychosocial Adjustment to Illness score (46.8 vs. 54.3, p  0.08). We conclude that...

Read More!

Going into the Groin: Injection into the Femoral Vein among people who inject drugs in three urban areas of England

Abstract

Background: There have been increasing concerns about injection into the femoral vein – groin injecting among people who inject drugs in a number of countries, though most studies have been small. The extent, reasons and harms associated with groin injecting are examined.
Method: Participants were recruited using respondent driven sampling (2006–2009). Weighted data was examined using bivariate analyses and logistic regression.
Results: The mean age was 32 years; 25% were women (N = 855). During the preceding 28 days, 94% had injected heroin and 13% shared needles/syringes. Overall, 53% reported ever groin injecting, with 9.8% first doing so at the same age as starting to inject. Common reasons given for groin injecting included: “Can’t get a vein elsewhere” (68%); “It is discreet” (18%); and “It is quicker” (14%). During the preceding 28 days, 41% had groin injected, for 77% this was the only body area used (for these “It is discreet” was more frequently given as a reason). In the multivariable analysis, groin...

Read More!

Disposition of Toxic Drugs & Chemicals in Man | Cocaine

Occurrence and Usage. Cocaine is the most potent of the naturally occurring central nervous system stimulants. The compound is found in the leaves of Erythroxylon coca, a South American shrub, in amounts of up to 2% by weight. It was first isolated in pure form in 1855, and has been widely utilized in medicine as a local anesthetic and increasingly by drug abusers for its stimulant properties. For anesthetic uses cocaine is administered topically as the hydrochloride in 1%-4% solutions for ophthalmological procedures and in 10%-20% solutions for the membranes of the nose and throat. When self-administered it is commonly taken as the hydrochloride by nasal insufflation or intravenous injection or as the free base by smoking, in doses of 10-120 mg.

Blood Concentrations. The chewing of powdered coca leaves containing 17-48 mg of cocaine produced peak plasma concentrations of 0.011-0.149 mg/L within 0.4-2 hours in 6 volunteers (Holmstedt et al., 1979). A 2 mg/kg (140 mg/ 70 kg) intranasal application of

Read More!

Disposition of Toxic Drugs & Chemicals in Man | Pentobarbital

Occurrence and Usage. Pentobarbital (pentobarbitone, Nembutal) is a very popular short-acting barbiturate derivative first prepared in 1930. The drug is available alone and in combination with other agents in amounts of 15-200 mg for oral, intramuscular, or rectal administration. It is supplied as the racemic mixture in the form of both the free acid and the sodium salt, the latter being strongly alkaline in aqueous solution.

Blood Concentrations. After a 5-minute intravenous infusion of 50 mg, plasma concentrations in 5 subjects averaged 1.18 mg/L (range, 1.05-1.33) at 0.08 hours, declining to 0.54 mg/L by 1 hour and 0.27 mg/L by 24 hours (Smith et al., 1973). Plasma concentrations averaged 3 mg/L at 6 minutes after intravenous injection of 100 mg of pentobarbital to 7 volunteers and fell to 1.6 mg/L by 1 hour, when they began to decline with a half-life of 22 hours (Ehrnebo, 1974). A single oral dose of 100 mg produced Occurrence and Usage. Pentobarbital (pentobarbitone, Nembutal) is a very popular short-acting barbiturate derivative first prepared in 1930. The drug is available alone and in combination with other agents in amounts of 15-200 mg for oral, intramuscular, or rectal administration. It is supplied as the racemic mixture in the form of both the free acid and the sodium salt, the latter being strongly alkaline in aqueous solution.

Blood Concentrations. After a 5-minute intravenous infusion of 50 mg, plasma concentrations in 5 subjects averaged 1.18 mg/L (range, 1.05-1.33) at 0.08 hours, declining to 0.54 mg/L by 1 hour and 0.27 mg/L by 24 hours (Smith et al., 1973). Plasma concentrations averaged 3 mg/L at 6 minutes after intravenous injection of 100 mg of pentobarbital to 7 volunteers and fell to 1.6 mg/L by 1 hour, when they began to decline with a half-life of 22 hours (Ehrnebo, 1974). A single oral dose of 100 mg produced...

Read More!

Disposition of Toxic Drugs & Chemicals in Man | Phenobarbital

Occurrence and Usage. Phenobarbital is a barbiturate derivative that has been used as a daytime sedative and very extensively as an anticonvulsant since 1912. Phenobarbital is an excellent inducer of drug-metabolizing microsomal enzymes and its use often results in the lowering of plasma levels of other drugs. Its low oil/water partition coefficient relative to other barbiturates is the basis for its slow accumulation in brain tissue and its limited metabolism. The drug is available as either the free acid or the sodium salt in an elixir or as tablets of 15-65 mg for oral use or in a 65-130 mg/mL solution for intramuscular or intravenous injection. It is often found in combination with bronchodilators, vasodilators, analgesics, and anticholinergic agents. It is generally administered to epileptic patients in oral doses of 60-200 mg daily, often in combination with other anticonvulsant drugs.

Blood Concentrations. A single 30 mg oral dose given to 3 volunteers produced an average peak serum concentration of

Read More!

Disposition of Toxic Drugs & Chemicals in Man | Primidone

Occurrence and Usage. Primidone (Mysoline), a desoxy derivative of phenobarbital, was synthesized in 1949 and first evaluated as an anticonvulsant in 1952. It is used frequently for the treatment of grand mal and temporal lobe seizures, in daily oral doses of 250-1500 mg. The drug is supplied as the free acid in tablets of 50 and 250 mg and as a 250 mg/5 mL suspension for oral administration.

Blood Concentrations. A single 250 mg oral dose of primidone given to 10 patients who were not receiving other anticonvulsants produced an average peak serum primidone concentration of 4.9 mg/L at 4 hours. Primidone concentrations declined with an average half-life of 15 hours (range, 9-22) in these patients, but patients receiving other anticonvulsant drugs exhibited primidone half-lives averaging 8 hours. The metabolites phenylethylmalonamide and phenobarbital were present at detectable levels within 24 or 48 hours, respectively, of the single primidone dose (Cloyd et al., 1981). After a 500 mg oral dose, one subject achieved a peak...

Read More!

Handbook of Drug Therapy in Psychiatry | Chapter 11 Movement Disorders and Neurologic Aspects of Psychotropic Drugs

Chapter. 11. Movement Disorders and Neurologic Aspects of Psychotropic Drugs

OVERVIEW

1. Acute dystonic reactions are common when starting antipsychotic chemotherapy - diphentydramine (Benadryl) 50 mg IV provides most rapid and safe relief within minutes. Alternatively, diphenhydramine may be given IM or benztropine may be given IV or IM ( 1-2 mg).

2. Parkinsonism is commonly seen, especially in the first few weeks of antipsychotic chemotherapy. There may be stiffness, reduced arm movement when walking, tremors, and sialorrhea. Prophylactic administration of an antiparkinsonian drug in low dosage 2 to 4 times daily may reduce the incidence and severity of acute extrapyramidal symptoms. These drugs should not be used prophylactically in the elderly or in patients with OBS. More potent antipsychotic agents with less anticholinergic potency are more likely to produce acute extrapyramidal (parkinsonian) effects. There is no evidence that neuroleptics with lower potential for producing acute EPS are less likely to produce the late-occurring neurologic syndrome known as tardive dyskinesia.

3. Akathisia is the most common acute EPS, and responds...

Read More!

Crack–Heroin Speedball Injection and its Implications for Vein care: Qualitative Study

Abstract

We report on an exploratory qualitative study investigating drug injectors' narratives of vein damage and groin (femoral vein) injection associated with the injection of crack-heroin speedball. We undertook 44 in-depth qualitative interviews among injectors of crack-heroin speedball in Bristol and London, England, in 2006. The data suggest an emerging culture of crack-based speedball injection. Injectors' narratives link speedball injection with shifts towards groin injection articulated as an acceptable risk, and not merely as a last resort in the face of increased vein deterioration associated with speedball. Accounts of vein damage linked to speedball emphasize 'missed hits' related to the local anaesthetic action of crack, the excess use of citric in the preparation of speedball injections and 'flushing' when making a hit. We find that groin injection persists despite an awareness of health risks and medical complications. We emphasize an urgent need for reviewing harm reduction in relation to vein care in the context of shifts to crack-based speedball injection, and the use of the femoral vein,...

Read More!

Risky injecting practices associated with snowballing: A qualitative study

Abstract

Crack cocaine injecting is associated with a higher prevalence of sharing behaviours, increased rates of hepatitis C infection and a higher likelihood of homelessness. The limited available evidence on snowballing (co-injecting of heroin and crack cocaine) suggests that this is associated with an increase in risky injection practices. This study sets out to explore the views and experiences of a group of drug users who 'snowball', with a view to inform the improvement of harm reduction services for such clients. This is a qualitative interview study of 18 male and female homeless drug users attending a needle exchange service in Nottingham, UK. For all those interviewed, snowballing represented a communal activity which affected peer injection practices. The individual perceptions of the terms 'sharing' and 'splitting' affected the levels of concerns when snowballs were used with others. The study highlighted the importance of knowing current vaccination and screening history of injecting partners in order to manage risk behaviour when drugs are used communally.

Read More!

Efficacy Of Lithium Carbonate On Public And Compulsive Masturbation: A Female Case With Mild Mental Disability.

Abstract

The efficacy of lithium carbonate in the first reported case of a female with mild mental disability who engaged in public and compulsive masturbation is described. The patient was born in 1975, and was 19 years old at first admission. A diagnosis of schizophrenia was initially suspected, therefore the patient was given medication including pimozide, haloperidol, carbamazepine, diazepam and levomepromazine. These medications, however, did not control the symptoms, and the patient showed several side effects, such as incontinence. Only lithium carbonate was efficacious among the medications administered; the patient's abnormal sexual behavior was significantly reduced and no conspicuous side effects were recognized. The mechanisms of lithium carbonate in controlling abnormal sexual behavior are discussed...

Read More!

Drug Policy Alliance Fact Sheet | Drug-Induced Homicide

Background

Overdose death rates in the United States have more than doubled over the past decade, surpassing motor vehicle accidents as the leading cause of injury-related death in the country.1 According to the Centers for Disease Control and Prevention, 47,055 people – an average of 128 people a day – died from drug overdoses in 2014.2 More than 18,000 overdose deaths in 2014 involved prescription opioids, such as hydrocodone (Vicodin™) and oxycodone (OxyContin™), while an additional 10,000 fatalities were attributed to heroin.3 Synthetic opioids, such as fentanyl, claimed nearly 5,550 lives.4 Policymakers are understandably alarmed at the overdose crisis with which they are now confronted. The public is calling for help and solutions. Elected officials unfamiliar with, or resistant to, harm reduction, prevention, and treatment interventions, however, are introducing punitive, counter-productive legislative measures in a misguided effort to reduce overdose fatalities. In particular, some states, including New York (AB 8616), Ohio (HB 270),..

Read More!

Exploring the Drugs-Crime Connection within the Electronic Dance Music and Hip-Hop Nightclub Scenes

ABSTRACT

This report explores how the cultural ethos, behavioral norms, activities, and individual and group identities (subcultural phenomena), inherent to the electronic dance music (EDMtrance, house, and techno music) and the hip hop/rap (HH) nightclub scenes in Philadelphia, Pennsylvania impact the relationship between alcohol, drugs, and crime, with additional attention to victimization (the ADC+V relationship). These two music scenes provide a major source of leisure and entertainment activity for many young adults today, yet the subcultures surrounding them are disparate and have been linked to diverse social problems, including alcohol and illegal drug abuse, criminal activity and victimization. This understudied, but increasingly popular social phenomenon has the potential to expand the scope of the drugs - crime debate to settings and populations not previously studied, and also to account for increasingly salient issues in contemporary society. We also elaborate on how the ADC+V relationship varies by two dimensions: the demographic make-up of...

Read More!

Side Effects of α-Blocker Use: Retrograde Ejaculation

Abstract

There are currently 5 α-blockers that are approved by the US Food and Drug Administration to treat lower urinary tract symptoms (LUTS). The American Urological Association guidelines committee believes that all α-blockers are equally effective. However, α-blockers differ in their likelihood of causing abnormal ejaculation. This article discusses the effects on ejaculatory function, and specifically retrograde ejaculation, of the currently available α-blockers being used to treat men with LUTS due to benign prostatic hyperplasia.

In the 1980s, the recognition by Lepor and colleagues that prostatic smooth muscle tension was mediated by α1-adrenoceptors led to the development of α-blockade as a treatment of lower urinary tract symptoms (LUTS).1 This dynamic component of prostatic obstruction accounts for approximately 40% of outflow obstruction due to benign prostatic hyperplasia (BPH).2 There are currently 5 α-blockers that are US Food and Drug Administration (FDA) approved to treat LUTS: doxazosin, terazosin, tamsulosin, alfuzosin, and silodosin. The American Urological Association...

Read More!